Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hsin-Yu Chang

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Oncoimmunology|January 29, 2024
DNMT1 constrains IFNβ-mediated anti-tumor immunity and PD-L1 expression to reduce the efficacy of radiotherapy and immunotherapyKevin Chih-Yang Huang, Shu-Fen Chiang, Tao-Wei Ke, et al.
In Vivo (Athens, Greece)|September 3, 2020
Casticin Inhibits <i>In Vivo</i> Growth of Xenograft Tumors of Human Oral Cancer SCC-4 CellsHung-Sheng Shang, Kuo-Wei Chen, Jiann-Shang Chou, et al.
Children (Basel, Switzerland)|December 23, 2023
Analgesic Effect of Low-Level Laser Therapy before Heel Lance for Pain Management in Healthy Term Neonates: A Randomized Controlled TrialBei-Yu Wu, Mei-Chen Ou-Yang, Chun-Ting Liu, et al.
Oncotarget|July 16, 2014
Discovery of selective inhibitors of Glutaminase-2, which inhibit mTORC1, activate autophagy and inhibit proliferation in cancer cellsYue-Zhi Lee, Cheng-Wei Yang, Hsin-Yu Chang, et al.
Cell Death & Disease|August 1, 2025
CHK1 inhibition increases the therapeutic response to radiotherapy via antitumor immunity in ARID1A-deficient colorectal cancerJhen-Yu Chen, Tao-Wei Ke, Shu-Fen Chiang, et al.
Cancer Immunology, Immunotherapy : CII|April 2, 2024
Activation of STING by the novel liposomal TLC388 enhances the therapeutic response to anti-PD-1 antibodies in combination with radiotherapyJhen-Yu Chen, Po-Yu Lin, Wei-Ze Hong, et al.
Cancer Immunology, Immunotherapy : CII|February 25, 2026
Heterologous prime-boost immunization of AAV-based neoantigen cancer vaccine induces anti-tumor immunity to inhibit tumor growth and relapseChi-Hsien Huang, Jhen-Yu Chen, Hsin-Yu Chang, et al.
Cancer Letters|November 15, 2025
Targeting DRP1 promotes radiotherapy-induced antitumor immunity via mitochondrial DNA-mediated cGAS-STING signaling in KRAS-mutated colorectal cancerYuan-Yao Tsai, Hsin-Yu Chang, Wei-Ze Hong, et al.
Bioinformatics (Oxford, England)|January 24, 2014
InterProScan 5: genome-scale protein function classificationPhilip Jones, David Binns, Hsin-Yu Chang, et al.
Biomaterials Science|November 26, 2021
A novel anti-tumor/anti-tumor-associated fibroblast/anti-mPEG tri-specific antibody to maximize the efficacy of mPEGylated nanomedicines against fibroblast-rich solid tumorMichael Chen, Ming-Thau Sheu, Tian-Lu Cheng, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Oncoimmunology|January 29, 2024
DNMT1 constrains IFNβ-mediated anti-tumor immunity and PD-L1 expression to reduce the efficacy of radiotherapy and immunotherapyKevin Chih-Yang Huang, Shu-Fen Chiang, Tao-Wei Ke, et al.
In Vivo (Athens, Greece)|September 3, 2020
Casticin Inhibits <i>In Vivo</i> Growth of Xenograft Tumors of Human Oral Cancer SCC-4 CellsHung-Sheng Shang, Kuo-Wei Chen, Jiann-Shang Chou, et al.
Children (Basel, Switzerland)|December 23, 2023
Analgesic Effect of Low-Level Laser Therapy before Heel Lance for Pain Management in Healthy Term Neonates: A Randomized Controlled TrialBei-Yu Wu, Mei-Chen Ou-Yang, Chun-Ting Liu, et al.
Oncotarget|July 16, 2014
Discovery of selective inhibitors of Glutaminase-2, which inhibit mTORC1, activate autophagy and inhibit proliferation in cancer cellsYue-Zhi Lee, Cheng-Wei Yang, Hsin-Yu Chang, et al.
Cell Death & Disease|August 1, 2025
CHK1 inhibition increases the therapeutic response to radiotherapy via antitumor immunity in ARID1A-deficient colorectal cancerJhen-Yu Chen, Tao-Wei Ke, Shu-Fen Chiang, et al.
Cancer Immunology, Immunotherapy : CII|April 2, 2024
Activation of STING by the novel liposomal TLC388 enhances the therapeutic response to anti-PD-1 antibodies in combination with radiotherapyJhen-Yu Chen, Po-Yu Lin, Wei-Ze Hong, et al.
Cancer Immunology, Immunotherapy : CII|February 25, 2026
Heterologous prime-boost immunization of AAV-based neoantigen cancer vaccine induces anti-tumor immunity to inhibit tumor growth and relapseChi-Hsien Huang, Jhen-Yu Chen, Hsin-Yu Chang, et al.
Cancer Letters|November 15, 2025
Targeting DRP1 promotes radiotherapy-induced antitumor immunity via mitochondrial DNA-mediated cGAS-STING signaling in KRAS-mutated colorectal cancerYuan-Yao Tsai, Hsin-Yu Chang, Wei-Ze Hong, et al.
Bioinformatics (Oxford, England)|January 24, 2014
InterProScan 5: genome-scale protein function classificationPhilip Jones, David Binns, Hsin-Yu Chang, et al.
Biomaterials Science|November 26, 2021
A novel anti-tumor/anti-tumor-associated fibroblast/anti-mPEG tri-specific antibody to maximize the efficacy of mPEGylated nanomedicines against fibroblast-rich solid tumorMichael Chen, Ming-Thau Sheu, Tian-Lu Cheng, et al.
Pageof 8